Nutrition
4 min read
December 10, 2022
Vitamin B6 and PMS

Vitamin B6 and PMS

Vitamin B6 has been studied for decades as a supportive intervention for Premenstrual Syndrome, with consistent evidence showing reductions in both psychological and physical symptoms. Clinical trials and meta-analyses suggest that therapeutic doses—well above dietary intake—may be required to achieve meaningful symptom relief.

The effectiveness of Vitamin B6 in the treatment of PMS dates back over 40 years. Results were noted, such as:

  • ‘Significant decreases in all symptoms’ (1)
  • 70% reporting good or partial response’ (2)
  • ‘Improvement in 63% of patients on pyridoxine’ (3)

The dose used within these studies ranged from 40-200mg (with a possible risk of toxicity at 200mg).

Only one patient of the 940 participating in these trials indicated the presence of any side effects that could be attributed to the neuropathy associated with pyridoxine toxicity. (4)

A meta-analysis of nine published trials involving almost 1,000 women with PMS found that vitamin B6 is more effective in reducing PMS symptoms than placebo. (5)

A double-blind, randomized controlled trial in 94 women found that 80 mg pyridoxine taken daily over the course of three cycles was associated with statistically significant reductions in a broad range of PMS symptoms, including:

  • Moodiness
  • Irritability
  • Forgetfulness
  • Bloating
  • Anxiety (6)

Below are my preferred dietary sources of Vitamin B6 per 100g:

  • Liver – 1mg
  • Salmon – 0.9mg
  • Sunflower Seeds – 1.33mg
  • Pistachios – 1.7mg

The recommended daily allowance sits around 1.3mg, which makes an easy target to obtain via food.

However, to achieve the dosage used in the above studies is between 30-153 times higher than the RDA, making it unachievable to obtain through diet alone.

As you can see here, Designs For Health provides 50mg of Vitamin B6 in just one capsule. This is in the form of Vitamin B6 in its most bioavailable form – P5P.

Magnesium and Vitamin B2 are required for the conversion of P5P. The deficiency rates of magnesium make this conversion much harder.

High protein diets or genetic susceptibilities (such as NBPF3) are factors that can increase the need for more Vitamin B6.

Have you ever used B6 for your PMS?

References:

  1. Goei and Abraham, 1983
  2. Brush, 1988
  3. Day, 1979
  4. London RS, et al. 1991
  5. Wyatt KM, et al. BMJ 1999
  6. Kashanian M, et al. 2007

Next news

A defining moment in human health

We are standing at the edge of a defining moment in human history — one that will reshape how health is understood, managed, and lived. Most practitioners won’t see it coming until it’s already here. The pace of change is no longer linear; it’s accelerating at a parabolic rate.

Over the next ten years, healthcare will undergo a larger transformation than it has in the past two hundred. What once took generations to evolve will soon happen within a single career span.

Why the next leap will eclipse the last 200 years

In the 1850s, global life expectancy hovered around 35 to 40 years. In industrial cities such as Manchester, it was recorded as low as 26. Up to 40% of children died before the age of five. Since then, humanity has doubled its average lifespan — one of the greatest achievements in modern history.

But that magnitude of progress will soon appear slow compared to what lies ahead. To understand why, we must look at how medicine has actually evolved — not as a straight line, but as a series of paradigm shifts.

Medicine has never moved in a straight line

Medicine does not evolve gradually. It moves through distinct eras, each defined by its dominant questions, tools, and limitations. Every era solves the problems of its time — and creates the blind spots of the next.

Medicine 1.0: survival through intervention

The age of infection and emergency care (1800s–1950s)

The first modern era of medicine was built around one core mission: survival. Its philosophy was direct and uncompromising — find the problem, cut it out, kill the pathogen. The focus was acute illness, trauma, and infectious disease. Surgery, antibiotics, vaccines, early imaging, and public health measures transformed mortality rates almost overnight.

Breakthroughs such as germ theory, penicillin, antisepsis, and sanitation saved millions of lives. Yet this era had little understanding of long-term health. There was no framework for chronic disease, prevention, or personalisation. Medicine 1.0 was exceptional in emergencies, but largely blind to the slow decline of health over time.

Medicine 2.0: managing disease, not health

The rise of chronic disease frameworks (1950s–2010s)

As life expectancy increased, the medical challenge shifted. Infectious disease gave way to chronic illness. Medicine 2.0 emerged with a new goal: management. Cardiovascular disease, diabetes, cancer, and mental health disorders became the dominant focus.

Pharmaceuticals, specialist referrals, evidence-based medicine, and large clinical trials defined this era. Disease was framed as isolated dysfunction within individual organ systems. While imaging, surgical techniques, and electronic health records advanced rapidly, care became fragmented. Poly-pharmacy increased, symptoms were suppressed rather than resolved, and patients often cycled endlessly through the system.

Medicine 2.0 kept people alive — but rarely helped them thrive.

Medicine 3.0: personalisation, prevention, and patterns

From symptoms to systems (2010s–2025)

The limitations of chronic disease management gave rise to a new way of thinking. Medicine 3.0 reframed health as a dynamic, interconnected system shaped by genetics, environment, lifestyle, and time. The focus shifted toward root causes, prevention, and optimisation.

Functional blood work, genomics, microbiome testing, wearables, and systems biology expanded what was possible. Practitioners began looking for patterns rather than isolated markers. Precision nutrition and functional reference ranges replaced one-size-fits-all recommendations.

Yet this era introduced new challenges. Data became abundant but scattered. Interpretation demanded high cognitive load. Standards varied widely, access remained inconsistent, and outcomes depended heavily on practitioner experience. While powerful, Medicine 3.0 was difficult to scale.

Many believe this is the peak of modern healthcare.

Why medicine 3.0 is not the end point

Despite its advances, Medicine 3.0 still relies on humans to manually integrate overwhelming amounts of data, make predictions, and adjust protocols over time. It improved insight — but not intelligence. It offered tools — but not true systems.

The next era changes that entirely.

Medicine 4.0: intelligence, automation, and decentralised health

Predictive, adaptive, and continuously evolving care (2025–2040+)

Medicine 4.0 represents a fundamental shift in how health is defined and managed. Health becomes a continuously evolving dataset, updated in real time across all stages of life. The focus moves from reaction to prediction, from static plans to adaptive systems, from intervention to self-correction.

Artificial intelligence, machine learning, digital twins, predictive analytics platforms, continuous multi-biomarker wearables, synthetic biology, and autonomous medical systems will allow health trajectories to be forecast before disease manifests. Diagnostics will become ambient. Treatment will adapt dynamically. Biology itself becomes increasingly programmable.

But this transformation comes with real challenges — data privacy, equity, over-reliance on technology, loss of human connection, and the risk of eroding individual agency. Intelligence must be guided, not blindly trusted.

Building the infrastructure for medicine 4.0

This is where MyHealthPrac enters — not as a response to Medicine 4.0, but as an early foundation for it.

MyHealthPrac is a decentralised health management system designed to translate complexity into clarity. Built on over a decade of research, line-by-line journal reviews, and clinically informed logic, it transforms vast amounts of health data into actionable, root-cause solutions. Hard-coded algorithms, pattern recognition, and predictive frameworks allow practitioners to move beyond interpretation and into intelligence.

This is not theory. It is not a distant vision.

Not the future of health — the next standard

Medicine 4.0 is not coming someday. It is arriving now. And the systems built today will determine whether this new era empowers practitioners and individuals — or overwhelms them.

MyHealthPrac is being built to lead that transition.

Philosophy
6 min read
The 4 ages of medicine and the one we haven’t met yet
The 4 ages of medicine and the one we haven’t met yet
Medicine is entering a new era. From infection control to intelligent, predictive systems, this article traces the evolution of healthcare — and explains why Medicine 4.0 will transform how the world manages health.
August 5, 2025

The paradigm of depression being a disease/disorder has evolved around the concept that neurotransmitters are primarily the root cause.

Yet, dysregulation in this field could very well be a symptom, coping mechanism and signal from a multitude of different issues ranging from inside, as well as outside of the body (as explained in my previous post).

The association of depression solely being linked to low levels of norepinephrine and serotonin is flawed throughout studies. There are many other variables that can result in this outcome.

Several studies indicate that as few as 25% of depressed patients have low levels of neurotransmitters, while paradoxically, some patients have abnormally high levels of neurotransmitters with no history of them ever being low.

Does the placement of depression into the category of disease/disorder attach a greater overwhelming thought process to the word than if we were to label it as a symptom?

One could argue that generally speaking, symptoms are alleviated with greater ease when compared with the disease.

It is easy to allow our identity to be taken hostage by adopting the ownership of depression and succumb to its depths.

Yet when we shift our thinking to understand that depression does not embody us as individuals, nor does it yield an element involved in modeling our identity, we shift our thoughts to a greater sense of self-empowerment.

We can overcome the ‘depression vs self’ mentality by accepting that depression is an adaptive and protective mechanism from the human body, accompanied with respect for the opportunity it brings forth to gain further insight into what needs nurturing.

I understand this is a challenging and delicate shift to take, yet the perception of the experience is paramount to one’s thoughts.

Could we disempower the shackling chains of emotional paralysis, gain buoyancy in the swamp of thoughts and restore vitality into one’s behaviour when depression is approached in the light of a symptom?

Can we utilise it as foresight with direction to what may require attention and care within our body and how we live?

This paradigm shift allows more of a harmonious level of awareness with the experience of depression and what possibilities it may bring.

References:

  1. Asberg M, et al. Arch Gen Psychiatry. 1976
  2. Mol Psychiatry. 2010 March
  3. Della FP, et al. Pharmacol Biochem Behav. 2012
  4. Della FP, et al. Behav Brain Res. 2012
  5. Della FP, et al. Metab Brain Dis. 2013

Mental Health
6 min read
Depression: disease or symptom?
Depression: disease or symptom?
Viewing depression as a symptom rather than an identity can foster self-empowerment, insight, and more personalised paths to healing—shifting focus from labels to understanding what the body and mind may be asking for attention and care.
December 10, 2022

Got plaque?

The conventional approach uses a process known as ‘Triple Therapy’ – this is the combination of two different antibiotics in-conjunction with a proton-pump inhibitor (which lowers HCL).

Not only does this have a low success rate, but it makes the host vulnerable to infection from other pathogens and parasites post-treatment. This is due to decreased stomach acid and a lessened ability to sterilise bacteria within food along with less competitive dominance within the gastrointestinal tract due to the eradication of the microbiota (pathogenic and beneficial species) within the gut, leaving available space to harbour unwanted bacteria.

H. Pylori is starting to develop resistance to antibiotics, making the conventional approach less and less effective – leading to the ‘thought’ process of adding more medication to the mix to overcome this resistance by using ‘Quadruple Therapy’.

The Health Protection Agency reports that the prevalence of H. Pylori antibiotic resistance varies within the UK depending on location, from 20-63% for metronidazole and 4.4-11% for clarithromycin. [11]

This is one factor explaining why as many as 20% of affected individuals have a reoccurring infection even after treatment.

Another factor for reinfection is the presence of H. Pylori in the oral cavity [1–3]; therefore, failure to eliminate H. Pylori from the mouth could lead to gastrointestinal reinfection.

Gingivitis and chronic periodontitis may be associated with H. Pylori infection and considered as a potential reservoir for bacteria. [4,5]

The plaque should be removed professionally, and oral hygiene procedures should be performed along with eradication strategies of H. Pylori [6] to increase the probability of success.

One could argue that an alternative approach yields much less risk to the host when compared with the iatrogenic complications and long-term hindrance from antibiotics (especially given that a single course of antibiotics can disturb the microbiome for unto 2-4 years post-treatment [12]).

The following has been found effective when addressing H. Pylori:

  • Bismuth subcitrate
  • Mastic gum
  • Goldenseal/Berberine
  • DGL Licorice wafers
  • Matula tea

The following foods have also been found beneficial:

  • Coconut oil
  • Manuka honey

All this has to be addressed with the appreciation of humans being a multi-dimensional and bi-directional organism.

Seeking advice from a trusted professional is always recommended when dealing with any health ailments.

References:

  1. Morales-Espinosa R, et al., Oral Microbiol Immunol. 2009
  2. Nguyen AM, et al., Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995
  3. Miyabayashi H, et al., Helicobacter. 2000
  4. Gebara EC, et al., J Clin Periodontol. 2006
  5. Dye BA, et al., Am J Public Health. 2002
  6. Eskandari A, et al. Med Oral Patol Oral Cir Bucal.
  7. Abro AH, et al. J Ayub Med Coll Abbottabad. 2011
  8. Saudi J Gastroenterol. 2014
  9. J Gastrointestin Liver Dis. 2011
  10. J Gastroenterol Hepatol. 2011
  11. Surveillance of Helicobacter pylori antibiotic resistance in England and Wales; Public Health England, 2008
  12. Jernberg, C, et al. 2010
Gut Health
6 min read
Pylori, plaque and protocols
Pylori, plaque and protocols
Reducing plaque, addressing oral health, and using targeted non-antibiotic strategies may improve eradication success while lowering long-term risks to the gut and immune system. A whole-body, professional-guided approach is essential.
December 10, 2022
Clarity, confidence, and real results start with one conversation. Let’s map your next chapter — together.